News
5d
News Medical on MSNNew technology brings antibiotic resistance surveillance to the fieldAntibiotics are one of the greatest triumphs in the history of medical science - but these lifesaving tools have a dark side.
6d
Health and Me on MSNAntibiotics Are Not The Answer! NHS Doctor Explains Why Viral Infections Do Not Need Such MedicationAntibiotics area great way to combat illnesses, helping people take effective measures against diseases. However, they are ...
Charts a New Course in Pharmacy: PSSL 2025 Scientific Sessions Spotlight Rational Drug Use, Innovation, and Global ...
The new ‘innovator passport’ will mean technology that has been robustly assessed by one NHS organisation can easily be ...
The University of Minnesota is stepping up efforts to identify biological threats that could trigger an epidemic, launching an institute to track disease-spreading infectious pathogens at the genetic ...
Since 2016, the Virginia Department of Health has confirmed 17 cases in the commonwealth, according to the study published in the Journal of Medical Entomology. Most of them were on the Eastern Shore ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of ...
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product and ...
Moderna’s experimental mRNA-based flu vaccine demonstrated a stronger immune response than a currently available standard flu shot in a late-stage phase 3 trial, clearing a path for regulatory ...
Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010, ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results